- Home
- Software Solutions
- Resources
- Corporate
Alnara Pharmaceuticals
Alnara Pharmaceuticals Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Cystic Fibrosis Exocrine Pancreatic Insufficiency | >ALTU-135 | Phase_III | Phase III ALTU-135 Safety... | NCT00449904 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Cystic Fibrosis Exocrine Pancreatic Insufficiency | >ALTU-135 | Phase_III | ALTU-135 Efficacy Trial i... | NCT00449878 |
| Terminated | Pancreatic Insufficiency | >Liprotamase (formerly ALTU-135) | Phase_III | Phase III ALTU-135 CP Saf... | NCT00500084 |